Invesco Biotechnology & Genome ETF
PBE
PBE
87 hedge funds and large institutions have $165M invested in Invesco Biotechnology & Genome ETF in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 22
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
87
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$6.06M | |
| 2 | +$4.62M | |
| 3 | +$2.46M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.11M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.64M |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$1.08M | |
| 3 | -$662K | |
| 4 |
NPC
National Planning Corporation
El Segundo,
California
|
-$335K |
| 5 |
Morgan Stanley
New York
|
-$327K |